The Structural Formula Of Nepafenac (Nevanac 01)
Nevanac
Product Images NDC 0078-0778
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Nevanac (NDC 0078-0778). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel Ndc 0078-0778-03 Sterile Nevanac® (nepafenac Ophthalmic Suspension) 0.1% 3 mL Novartis (Nevanac 02)
This is a medication in eye-drop form with active ingredient nepafenac 0%. The other ingredients include a small concentration of benzalkonium chloride as a preservative, carbomer, edetate disodium, purified water, sodium chloride, sodium hydroxide, and boric acid. This medication is typically used for ophthalmic purposes and comes in a 0.1% suspension form. The suggested dosage is one drop in the affected eye(s) three times daily and should be shaken before use. It should be stored at a temperature between 2-25°C. The medication is produced by the company Novartis.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
